Efficacy and Safety of Sintilimab and Apatinib Combined Chemotherapy in Breast Cancer
Clinical trial NCT04722718 · UNKNOWN
Trial details
- NCT number
- NCT04722718
- Sponsor
- Jiuda Zhao
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-02-01
- Primary completion
- 2022-12-31
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.